1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow CORT 108297: new trials by email Literature Review of CORT 108297 trials Research Report on CORT 108297
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study) CORT108297, Placebo - PTSD | Phase 2 | Completed | VA Office of Research and Development | 39 | 2022-10-15 | 2026-10-27 |
| Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X) CORT108297, Placebo - Mild Cognitive Impairment, Alzheimer Disease | Phase 2 | Recruiting | Johns Hopkins University | 52 | 2021-06-28 | 2026-07-13 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Dementia (1) · Memory Disorders (1) · Stress Disorders, Post-Traumatic (1)
Johns Hopkins University (1) · VA Office of Research and Development (1)
United States (2)
Cynthia A Munro, PhD (1) · Thomas C. Neylan, MD (1)
I01CX001917 (1)